General Electric must reimburse a competitor $8.3 million for ads it has already run and $3 million for future ads after a GE subsidiary claimed that its x-ray contrast agent was better than the competitor's--a misconstruction of a clinical study, said the court. But which is actually better? The experts were divided, and "the weight of clinical evidence," said the court, did not point either way.